Protocol Details
Longitudinal Sample Collection and Tracking for the Developmental Therapeutics Clinic, National Cancer Institute
This study is currently recruiting participants.
Summary
Number |
17-C-0156 |
Sponsoring Institute |
National Cancer Institute (NCI) |
Recruitment Detail |
Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 18 Years
Max Age: 120 Years |
Referral Letter Required |
No |
Population Exclusion(s) |
Pregnant Women;
Adults who are or may become unable to consent;
Fetuses;
Children |
Keywords |
Pharmacodynamics;
Tissue Collection;
Tissue Biopsies;
Biospecimen;
Assay Development;
Natural History |
Recruitment Keyword(s) |
None |
Condition(s) |
Neoplasms;
Lymphoma |
Investigational Drug(s) |
None |
Investigational Device(s) |
None |
Intervention(s) |
None |
Supporting Site |
National Cancer Institute |
Background:
People who join a study in the Developmental Therapeutics Clinic (DTC) have tests. These include blood draws and biopsies. Researchers collect data from these samples. Some people take part in more than one study at the DTC. At this time, data are connected only with one single study. Researchers want to access people s medical records. This will allow them to link the research data from all their studies they have or will take part in. Researchers also want to collect medical data about their diagnosis and treatment history. This will allow them to see how their cancer reacted to different drugs over time.
Objective:
To enter people into a master protocol to connect research sample and treatment data across DTC studies.
Eligibility:
People ages 18 and older who are being evaluated or treated for cancer in the DTC
Design:
Participants will allow researchers to look at all the data from their research samples. This includes those from their current, past, and any future NIH studies.
Participants will allow researchers to access some of their medical data. This includes age, diagnosis, treatment history, and response to treatment.
Participants will provide no new samples.
Eligibility
INCLUSION CRITERIA:
- Patients who are being evaluated and/or treated for cancer or benign tuumors in the Developmental Therapeutics Clinic at the NIH Clinical Center
- Ability to understand and willingness to sign a written informed consent document indicating their willingness to have data from their tissue or biologic fluid research specimens and limited medial information used for research as outlined in this protocol and to allow protocol staff access to the CRIS database and their Medical Records Number (MRN).
- Age greater than or equal to 18 years
ECLUSION CRITERIA:
None
Citations:
Not Provided
Contacts:
Clinical Trials Number:
NCT03269578